February 20, 2009 (FinancialWire) -- Mylan Inc. (NASDAQ: MYL) said that its chief financial officer, Edward J. Borkowski, will transition out of his role over the next several months.

According to the company, Borkowski, who was with the firm for seven years, will remain with Mylan until a successor is named and in place.

Borkowski said, "As Mylan has entered into the next phase of executing on its global operational goals, I believe that it is an appropriate time for me to be able to move on to new challenges."

Mylan said has retained the executive recruitment firm Korn/Ferry International to lead the search for Borkowski's replacement.

Pittsburgh-based Mylan is a generic and specialty pharmaceutical company that provides products to customers in more than 140 countries and territories.

In addition to its product portfolio and product pipeline, the company owns a controlling interest in an active pharmaceutical ingredient manufacturer and operates a specialty business focused on respiratory and allergy therapies.

FinancialWire" ( http://www.financialwire.net ), an independent, proprietary news service of Investrend Communications, Inc., receives no compensation for its news or opinions. Further disclosure is at http://www.investrend.com/articles/secondlevel.asp?level=472 . To contact FinancialWire" write to inquiries@financialwire.net .

Free annual reports for companies mentioned in the news are accessible via http://investrend.ar.wilink.com/?level=279 .

Copyright(C)2009 by financialwire.net, Inc. All rights reserved.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.